Prevention of breast cancer skeletal metastases with parathyroid hormone

Advanced breast cancer is frequently associated with skeletal metastases and accelerated bone loss. Recombinant parathyroid hormone [teriparatide, PTH(1-34)] is the first anabolic agent approved in the US for treatment of osteoporosis. While signaling through the PTH receptor in the osteoblast linea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCI Insight
Autors principals: Swami, Srilatha, Johnson, Joshua, Bettinson, Lance A., Kimura, Takaharu, Zhu, Hui, Albertelli, Megan A., Johnson, Rachelle W., Wu, Joy Y.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5621896/
https://ncbi.nlm.nih.gov/pubmed/28878134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90874
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars